AMPCO PITTSBURGH CORP Income Taxes Disclosure
NOTE 21 – INCOME TAXES:
(Loss) income from operations before income taxes for the years ended December 31, 2025 and 2024 is summarized below. (Loss) income from operations before income taxes for certain foreign entities is classified differently for book reporting and income tax reporting purposes.
|
|
2025 |
|
|
2024 |
|
||
Domestic |
|
$ |
(8,375 |
) |
|
$ |
3,331 |
|
Foreign |
|
|
(55,047 |
) |
|
|
1,715 |
|
(Loss) income from operations before income taxes |
|
$ |
(63,422 |
) |
|
$ |
5,046 |
|
The income tax provision for the years ended December 31, 2025 and 2024 consisted of the following:
|
|
2025 |
|
|
2024 |
|
||
Current: |
|
|
|
|
|
|
||
Federal |
|
$ |
13 |
|
|
$ |
— |
|
State |
|
|
145 |
|
|
|
22 |
|
Foreign |
|
|
1,173 |
|
|
|
2,414 |
|
Current income tax provision |
|
|
1,331 |
|
|
|
2,436 |
|
Deferred: |
|
|
|
|
|
|
||
Federal |
|
|
(10,542 |
) |
|
|
1,176 |
|
State |
|
|
(1,873 |
) |
|
|
549 |
|
Foreign |
|
|
2,122 |
|
|
|
(1,959 |
) |
Increase in valuation allowance, net |
|
|
9,082 |
|
|
|
493 |
|
Deferred income tax (benefit) provision |
|
|
(1,211 |
) |
|
|
259 |
|
Total income tax provision |
|
$ |
120 |
|
|
$ |
2,695 |
|
The foreign income tax provision for 2025 benefited from a lower statutory income tax rate on the earnings of the Corporation's majority-owned Chinese joint venture as a result of the joint venture qualifying as a high-tech enterprise (“HTE”). As an HTE, the earnings of the Chinese joint venture are taxed at a rate of 15% (versus 25%). The effect on the income tax provision was a benefit of $1,000 for 2025 when compared to the income tax provision for 2024.
The state income tax provision for 2025 consisted primarily of Georgia, North Carolina, Pennsylvania, and Virginia. The state income provision for 2024 consisted primarily of Pennsylvania and Virginia.
The difference between statutory U.S. federal income tax and the Corporation’s effective income tax for the years ended December 31, 2025 and 2024 was as follows:
|
|
2025 |
|
|
2024 |
|
||||||||
|
|
Amount |
|
Percent |
|
|
Amount |
|
Percent |
|
||||
U.S. federal income tax, computed at the statutory rate |
|
$ |
(13,319 |
) |
|
21.0 |
% |
|
$ |
1,060 |
|
|
21.0 |
% |
State and local income taxes, net of federal tax benefit |
|
|
(934 |
) |
|
1.5 |
% |
|
|
323 |
|
|
6.4 |
% |
Foreign tax effects: |
|
|
|
|
|
|
|
|
|
|
||||
China |
|
|
|
|
|
|
|
|
|
|
||||
Statutory tax rate difference from non-U.S. earnings |
|
|
(288 |
) |
|
0.5 |
% |
|
|
209 |
|
|
4.1 |
% |
Research and development |
|
|
(349 |
) |
|
0.6 |
% |
|
|
(190 |
) |
|
-3.8 |
% |
Changes in valuation allowance |
|
|
57 |
|
|
-0.1 |
% |
|
|
(3 |
) |
|
-0.1 |
% |
Enacted changes in tax laws or rates |
|
|
(695 |
) |
|
1.1 |
% |
|
|
— |
|
|
0.0 |
% |
Other |
|
|
24 |
|
|
0.0 |
% |
|
|
57 |
|
|
1.1 |
% |
United Kingdom |
|
|
|
|
|
|
|
|
|
|
||||
Statutory tax rate difference from non-U.S. earnings |
|
|
(627 |
) |
|
1.0 |
% |
|
|
(312 |
) |
|
-6.2 |
% |
Changes in valuation allowance |
|
|
(2,836 |
) |
|
4.5 |
% |
|
|
1,956 |
|
|
38.8 |
% |
Deconsolidation of UES-UK |
|
|
16,534 |
|
|
-26.1 |
% |
|
|
— |
|
|
0.0 |
% |
Other |
|
|
10 |
|
|
0.0 |
% |
|
|
64 |
|
|
1.3 |
% |
Sweden |
|
|
|
|
|
|
|
|
|
|
||||
Statutory tax rate difference from non-U.S. earnings |
|
|
12 |
|
|
0.0 |
% |
|
|
3 |
|
|
0.1 |
% |
Changes in valuation allowance |
|
|
528 |
|
|
-0.8 |
% |
|
|
4 |
|
|
0.1 |
% |
Return-to-provision adjustments |
|
|
114 |
|
|
-0.2 |
% |
|
|
169 |
|
|
3.3 |
% |
Other |
|
|
118 |
|
|
-0.2 |
% |
|
|
17 |
|
|
0.3 |
% |
Other foreign jurisdictions |
|
|
(31 |
) |
|
0.0 |
% |
|
|
33 |
|
|
0.7 |
% |
Changes in valuation allowances |
|
|
10,934 |
|
|
-17.2 |
% |
|
|
(1,286 |
) |
|
-25.5 |
% |
Nontaxable or nondeductible items: |
|
|
|
|
|
|
|
|
|
|
||||
Stock-based compensation |
|
|
161 |
|
|
-0.3 |
% |
|
|
279 |
|
|
5.5 |
% |
Deductible compensation limitation |
|
|
216 |
|
|
-0.3 |
% |
|
|
112 |
|
|
2.2 |
% |
Worthless stock deduction of UES-UK |
|
|
(8,088 |
) |
|
12.8 |
% |
|
|
— |
|
|
0.0 |
% |
Deconsolidation of UES-UK |
|
|
(1,471 |
) |
|
2.3 |
% |
|
|
— |
|
|
0.0 |
% |
Other |
|
|
36 |
|
|
-0.1 |
% |
|
|
35 |
|
|
0.7 |
% |
Other – net |
|
|
14 |
|
|
0.0 |
% |
|
|
165 |
|
|
3.3 |
% |
Total income tax provision |
|
$ |
120 |
|
|
-0.2 |
% |
|
$ |
2,695 |
|
|
53.4 |
% |
Income taxes paid, net of refunds, by jurisdiction as of December 31, 2025 and 2024 were as follows:
|
|
2025 |
|
|
2024 |
|
||
U.S. Federal |
|
$ |
20 |
|
|
$ |
592 |
|
U.S. State |
|
|
35 |
|
|
|
(46 |
) |
Non-U.S. |
|
|
|
|
|
|
||
Slovenia |
|
|
1,217 |
|
|
|
862 |
|
China |
|
|
545 |
|
|
|
1,103 |
|
Income tax payments, net of refunds |
|
$ |
1,817 |
|
|
$ |
2,511 |
|
Deferred income tax assets and liabilities as of December 31, 2025 and 2024 are summarized in the following table. Unremitted earnings of the Corporation’s non-U.S. subsidiaries and affiliates are deemed to be permanently re-invested and, accordingly, no deferred income tax liability has been recorded. If the Corporation were to remit any foreign earnings to the U.S., the estimated tax impact would be insignificant.
|
|
2025 |
|
|
2024 |
|
||
Assets: |
|
|
|
|
|
|
||
Net operating loss – domestic |
|
$ |
23,518 |
|
|
$ |
14,633 |
|
Net operating loss – foreign |
|
|
6,271 |
|
|
|
10,514 |
|
Net operating loss – state |
|
|
3,756 |
|
|
|
3,095 |
|
Asbestos-related liability |
|
|
17,863 |
|
|
|
16,503 |
|
Sale-leaseback |
|
|
10,880 |
|
|
|
10,510 |
|
Employment – related liabilities |
|
|
4,657 |
|
|
|
5,330 |
|
Interest expense limitation |
|
|
4,419 |
|
|
|
3,141 |
|
Pension liability – foreign |
|
|
1,058 |
|
|
|
29 |
|
Pension liability – domestic |
|
|
832 |
|
|
|
2,283 |
|
Unearned revenue |
|
|
1,478 |
|
|
|
676 |
|
Inventory related |
|
|
1,434 |
|
|
|
210 |
|
Impairment charge associated with investment in Anhui |
|
|
963 |
|
|
|
958 |
|
Operating lease right-of-use liabilities |
|
|
918 |
|
|
|
1,124 |
|
Capital loss carryforwards |
|
|
— |
|
|
|
189 |
|
Other |
|
|
378 |
|
|
|
608 |
|
Gross deferred income tax assets |
|
|
78,425 |
|
|
|
69,803 |
|
Valuation allowance |
|
|
(51,110 |
) |
|
|
(41,019 |
) |
|
|
|
27,315 |
|
|
|
28,784 |
|
Liabilities: |
|
|
|
|
|
|
||
Depreciation |
|
|
(19,868 |
) |
|
|
(24,190 |
) |
Operating lease assets |
|
|
(918 |
) |
|
|
(1,124 |
) |
Intangible assets – finite life |
|
|
(324 |
) |
|
|
(15 |
) |
Intangible assets – indefinite life |
|
|
(471 |
) |
|
|
(430 |
) |
Estimated recovery - UES-UK |
|
|
(1,650 |
) |
|
|
— |
|
Other |
|
|
(512 |
) |
|
|
(624 |
) |
Gross deferred income tax liabilities |
|
|
(23,743 |
) |
|
|
(26,383 |
) |
Net deferred income tax assets |
|
$ |
3,572 |
|
|
$ |
2,401 |
|
At December 31, 2025, the Corporation has U.S. federal net operating loss carryforwards of $111,952, which can be carried forward indefinitely but will be limited to 80% of the Corporation’s taxable income in any given year. Additionally, at December 31, 2025, the Corporation had state net operating loss carryforwards of $93,393, which begin to expire in 2026, and foreign net operating loss carryforwards of $30,328, which do not expire.
Valuation allowances are recorded against the majority of the Corporation’s deferred income tax assets. The Corporation will maintain the valuation allowances until there is sufficient evidence to support the reversal of all or some portion of the allowances. Given the Corporation’s anticipated future earnings in Sweden and the United States, the Corporation believes there is a reasonable possibility within the next 12 months, sufficient positive evidence may become available to allow the Corporation to conclude some portion of the valuation allowance will no longer be needed. Release of any portion of the valuation allowance would result in the recognition of deferred income tax assets on the consolidated balance sheet and a decrease to income tax expense in the period the release is recorded. The exact timing and the amount of the valuation allowance released are subject to, among many items, the level of profitability achieved. Once the valuation allowance is completely reversed, a tax provision would be recognized on future earnings.
Unrecognized tax benefits and changes in unrecognized tax benefits for the years ended December 31, 2025 and 2024 are insignificant. If the unrecognized tax benefits were recognized, the effect on the Corporation’s effective income tax rate would also be insignificant. The amount of penalties and interest recognized in the consolidated balance sheets as of December 31, 2025 and 2024 and in the consolidated statements of operations for 2025 and 2024 is insignificant.
On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the United States. OBBBA introduces multiple tax law and legislative changes, including modifications to income tax provisions such as business interest expense limitations, domestic research and development expenses and U.S. taxation of international earnings. It also reinstates 100% bonus depreciation for property acquired and placed into service on or after January 19, 2025. The Corporation has recognized the effects of the OBBBA provisions in its financial results to the extent they are applicable for the year ended December 31, 2025. Certain provisions of the OBBBA have effective dates after December 31, 2025. The Corporation will continue to evaluate the impact of these provisions on its future consolidated financial statements.
The Corporation is subject to taxation and files income tax returns in the United States, various states and foreign jurisdictions, and remains subject to examination by tax authorities for tax years 2022 – 2025.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 16, 2026 | Showing above |
| 2024 | Mar 17, 2025 | |
| 2023 | Mar 25, 2024 | |
| 2022 | Mar 21, 2023 | |
| 2021 | Mar 17, 2022 | |
| 2020 | Mar 26, 2021 | |
| 2019 | Mar 16, 2020 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.